S. Lui

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients.

B. Tomlinson, Hon-Kit Lee, C. Ho, 2013, Pharmacogenomics.

Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies.

B. Tomlinson, G. Ko, Miao Hu, 2013, International journal of cardiology.

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients

B. Tomlinson, L. Baum, V. Lee, 2010, Pharmacogenetics and genomics.

The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin[S]

B. Tomlinson, L. Tam, E. Li, 2012, Journal of Lipid Research.

ABCG2 Polymorphism Is Associated With the Low‐Density Lipoprotein Cholesterol Response to Rosuvastatin

B. Tomlinson, L. Baum, V. Lee, 2010, Clinical pharmacology and therapeutics.

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients

B. Tomlinson, L. Baum, L. Tam, 2010, Pharmacogenetics and genomics.